Tomasz Sacha

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 29

Top Venues

Leukemia

Scientific reports

American journal of hematology

EJHaem

Uniwersytet Jagielloński Collegium Medicum

Uniwersytet Jagielloński Collegium Medicum (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Uniwersytet Jagielloński Collegium Medicum Oct 01 1992

Poland

Lecturer :: Hematology

Education History

Uniwersytet Jagielloński Collegium Medicum Oct 01 1992

Poland

PHD :: Hematology

Publications

Annamaria Brioli, Elza Lomaia, Christian Fabisch, Tomasz Sacha, Hana Klamova, Elena Morozova, Aleksandra Golos, Philipp Ernst, Ulla Olsson-Stromberg, Daniela Zackova, Franck E Nicolini, Han Bao, Fausto Castagnetti, Elżbieta Patkowska, Jiri Mayer, Klaus Hirschbühl, Helena Podgornik, Edyta Paczkowska, Anne Parry, Thomas Ernst, Astghik Voskanyan, Elzbieta Szczepanek, Susanne Saussele, Georg-Nikolaus Franke, Alexander Kiani, Edgar Faber, Stefan W Krause, Luis Felipe Casado, Krzysztof Lewandowski, Matthias Eder, Peter Anhut, Justyna Gil, Thomas Südhoff, Holger Hebart, Sonja Heibl, Markus Pfirrmann, Andreas Hochhaus, Michael Lauseker
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry. Leukemia 38 (5) (2024)
Annamaria Brioli, Elza Lomaia, Christian Fabisch, Tomasz Sacha, Hana Klamova, Elena Morozova, Aleksandra Golos, Philipp Ernst, Ulla Olsson-Stromberg, Daniela Zackova, Franck E Nicolini, Han Bao, Fausto Castagnetti, Elżbieta Patkowska, Jiri Mayer, Klaus Hirschbühl, Helena Podgornik, Edyta Paczkowska, Anne Parry, Thomas Ernst, Astghik Voskanyan, Elzbieta Szczepanek, Susanne Saussele, Georg-Nikolaus Franke, Alexander Kiani, Edgar Faber, Stefan W Krause, Luis Felipe Casado, Krzysztof Lewandowski, Matthias Eder, Peter Anhut, Justyna Gil, Thomas Südhoff, Holger Hebart, Sonja Heibl, Markus Pfirrmann, Andreas Hochhaus, Michael Lauseker
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry. Leukemia 38 (5) (2024)
Stephen T Oh, Srdan Verstovsek, Vikas K Gupta, Uwe Platzbecker, Timothy Devos, Jean-Jacques Kiladjian, Donal P McLornan, Andrew Charles Perkins, Maria Laura Fox, Mary Frances McMullin, Adam J Mead, Miklos Egyed, Jiri Mayer, Tomasz Sacha, Jun Kawashima, Mei Huang, Bryan Strouse, Ruben Mesa
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis. EJHaem 5 (1) (2024)
Annamaria Brioli, Elza Lomaia, Christian Fabisch, Tomasz Sacha, Hana Klamova, Elena Morozova, Aleksandra Golos, Philipp Ernst, Ulla Olsson-Stromberg, Daniela Zackova, Franck E Nicolini, Han Bao, Fausto Castagnetti, Elżbieta Patkowska, Jiri Mayer, Klaus Hirschbühl, Helena Podgornik, Edyta Paczkowska, Anne Parry, Thomas Ernst, Astghik Voskanyan, Elzbieta Szczepanek, Susanne Saussele, Georg-Nikolaus Franke, Alexander Kiani, Edgar Faber, Stefan W Krause, Luis Felipe Casado, Krzysztof Lewandowski, Matthias Eder, Peter Anhut, Justyna Gil, Thomas Südhoff, Holger Hebart, Sonja Heibl, Markus Pfirrmann, Andreas Hochhaus, Michael Lauseker
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry. Leukemia 38 (5) (2024)
Annamaria Brioli, Elza Lomaia, Christian Fabisch, Tomasz Sacha, Hana Klamova, Elena Morozova, Aleksandra Golos, Philipp Ernst, Ulla Olsson-Stromberg, Daniela Zackova, Franck E Nicolini, Han Bao, Fausto Castagnetti, Elżbieta Patkowska, Jiri Mayer, Klaus Hirschbühl, Helena Podgornik, Edyta Paczkowska, Anne Parry, Thomas Ernst, Astghik Voskanyan, Elzbieta Szczepanek, Susanne Saussele, Georg-Nikolaus Franke, Alexander Kiani, Edgar Faber, Stefan W Krause, Luis Felipe Casado, Krzysztof Lewandowski, Matthias Eder, Peter Anhut, Justyna Gil, Thomas Südhoff, Holger Hebart, Sonja Heibl, Markus Pfirrmann, Andreas Hochhaus, Michael Lauseker
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry. Leukemia (2024)
Annamaria Brioli, Elza Lomaia, Christian Fabisch, Tomasz Sacha, Hana Klamova, Elena Morozova, Aleksandra Golos, Philipp Ernst, Ulla Olsson-Stromberg, Daniela Zackova, Franck E Nicolini, Han Bao, Fausto Castagnetti, Elżbieta Patkowska, Jiri Mayer, Klaus Hirschbühl, Helena Podgornik, Edyta Paczkowska, Anne Parry, Thomas Ernst, Astghik Voskanyan, Elzbieta Szczepanek, Susanne Saussele, Georg-Nikolaus Franke, Alexander Kiani, Edgar Faber, Stefan W Krause, Luis Felipe Casado, Krzysztof Lewandowski, Matthias Eder, Peter Anhut, Justyna Gil, Thomas Südhoff, Holger Hebart, Sonja Heibl, Markus Pfirrmann, Andreas Hochhaus, Michael Lauseker
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry. Leukemia 38 (5) (2024)
Stephen T Oh, Srdan Verstovsek, Vikas K Gupta, Uwe Platzbecker, Timothy Devos, Jean-Jacques Kiladjian, Donal P McLornan, Andrew Charles Perkins, Maria Laura Fox, Mary Frances McMullin, Adam J Mead, Miklos Egyed, Jiri Mayer, Tomasz Sacha, Jun Kawashima, Mei Huang, Bryan Strouse, Ruben Mesa
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis. EJHaem 5 (1) (2024)
Stephen T Oh, Srdan Verstovsek, Vikas K Gupta, Uwe Platzbecker, Timothy Devos, Jean-Jacques Kiladjian, Donal P McLornan, Andrew Charles Perkins, Maria Laura Fox, Mary Frances McMullin, Adam J Mead, Miklos Egyed, Jiri Mayer, Tomasz Sacha, Jun Kawashima, Mei Huang, Bryan Strouse, Ruben Mesa
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis. EJHaem 5 (1) (2024)
Katerina Machova Polakova, Ali Albeer, Vaclava Polivkova, Monika Krutska, Katerina Vlcanova, Nikola Curik, Alice Fabarius, Hana Klamova, Birgit Spiess, Cornelius F Waller, Tim Henrik Brümmendorf, Jolanta Dengler, Volker Kunzmann, Andreas Burchert, Petra Belohlavkova, Mohamed El Missiry, Edgar Faber, Jiří Mayer, Daniela Zackova, Panayiotis Panayiotidis, Johan Richter, Henrik Hjorth-Hansen, Magdalena Kamińska, Magdalena Płonka, Elżbieta Szczepanek, Monika Szarejko, Grażyna Bober, Iwona Hus, Olga Grzybowska-Izydorczyk, Ewa Wasilewska, Edyta Paczkowska, Joanna Niesiobędzka-Krężel, Krzysztof Giannopoulos, Francois X Mahon, Tomasz Sacha, Susanne Saussele, Markus Pfirrmann
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib. Leukemia 38 (2) (2023)
Katerina Machova Polakova, Ali Albeer, Vaclava Polivkova, Monika Krutska, Katerina Vlcanova, Nikola Curik, Alice Fabarius, Hana Klamova, Birgit Spiess, Cornelius F Waller, Tim Henrik Brümmendorf, Jolanta Dengler, Volker Kunzmann, Andreas Burchert, Petra Belohlavkova, Mohamed El Missiry, Edgar Faber, Jiří Mayer, Daniela Zackova, Panayiotis Panayiotidis, Johan Richter, Henrik Hjorth-Hansen, Magdalena Kamińska, Magdalena Płonka, Elżbieta Szczepanek, Monika Szarejko, Grażyna Bober, Iwona Hus, Olga Grzybowska-Izydorczyk, Ewa Wasilewska, Edyta Paczkowska, Joanna Niesiobędzka-Krężel, Krzysztof Giannopoulos, Francois X Mahon, Tomasz Sacha, Susanne Saussele, Markus Pfirrmann
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib. Leukemia 38 (2) (2023)
Katerina Machova Polakova, Ali Albeer, Vaclava Polivkova, Monika Krutska, Katerina Vlcanova, Nikola Curik, Alice Fabarius, Hana Klamova, Birgit Spiess, Cornelius F Waller, Tim Henrik Brümmendorf, Jolanta Dengler, Volker Kunzmann, Andreas Burchert, Petra Belohlavkova, Mohamed El Missiry, Edgar Faber, Jiří Mayer, Daniela Zackova, Panayiotis Panayiotidis, Johan Richter, Henrik Hjorth-Hansen, Magdalena Kamińska, Magdalena Płonka, Elżbieta Szczepanek, Monika Szarejko, Grażyna Bober, Iwona Hus, Olga Grzybowska-Izydorczyk, Ewa Wasilewska, Edyta Paczkowska, Joanna Niesiobędzka-Krężel, Krzysztof Giannopoulos, Francois X Mahon, Tomasz Sacha, Susanne Saussele, Markus Pfirrmann
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib. Leukemia 38 (2) (2023)
Katerina Machova Polakova, Ali Albeer, Vaclava Polivkova, Monika Krutska, Katerina Vlcanova, Nikola Curik, Alice Fabarius, Hana Klamova, Birgit Spiess, Cornelius F Waller, Tim Henrik Brümmendorf, Jolanta Dengler, Volker Kunzmann, Andreas Burchert, Petra Belohlavkova, Mohamed El Missiry, Edgar Faber, Jiří Mayer, Daniela Zackova, Panayiotis Panayiotidis, Johan Richter, Henrik Hjorth-Hansen, Magdalena Kamińska, Magdalena Płonka, Elżbieta Szczepanek, Monika Szarejko, Grażyna Bober, Iwona Hus, Olga Grzybowska-Izydorczyk, Ewa Wasilewska, Edyta Paczkowska, Joanna Niesiobędzka-Krężel, Krzysztof Giannopoulos, Francois X Mahon, Tomasz Sacha, Susanne Saussele, Markus Pfirrmann
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib. Leukemia 38 (2) (2023)
Katerina Machova Polakova, Ali Albeer, Vaclava Polivkova, Monika Krutska, Katerina Vlcanova, Nikola Curik, Alice Fabarius, Hana Klamova, Birgit Spiess, Cornelius F Waller, Tim Henrik Brümmendorf, Jolanta Dengler, Volker Kunzmann, Andreas Burchert, Petra Belohlavkova, Mohamed El Missiry, Edgar Faber, Jiří Mayer, Daniela Zackova, Panayiotis Panayiotidis, Johan Richter, Henrik Hjorth-Hansen, Magdalena Kamińska, Magdalena Płonka, Elżbieta Szczepanek, Monika Szarejko, Grażyna Bober, Iwona Hus, Olga Grzybowska-Izydorczyk, Ewa Wasilewska, Edyta Paczkowska, Joanna Niesiobędzka-Krężel, Krzysztof Giannopoulos, Francois X Mahon, Tomasz Sacha, Susanne Saussele, Markus Pfirrmann
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib. Leukemia (2023)
Srdan Verstovsek, Ruben A Mesa, Vikas K Gupta, David Lavie, Viviane Dubruille, Nathalie Cambier, Uwe Platzbecker, Marek Hus, Blanca Xicoy Cirici, Stephen T Oh, Jean-Jacques Kiladjian, Alessandro M Vannucchi, Aaron T Gerds, Miklos Egyed, Jiri Mayer, Tomasz Sacha, Jun Kawashima, Marc Morris, Mei Huang, Claire N Harrison
Momelotinib Long-Term Safety and Survival in Myelofibrosis: Integrated Analysis of Phase 3 Randomized-Controlled Trials. Blood advances (2023)
Katerina Machova Polakova, Ali Albeer, Vaclava Polivkova, Monika Krutska, Katerina Vlcanova, Nikola Curik, Alice Fabarius, Hana Klamova, Birgit Spiess, Cornelius F Waller, Tim Henrik Brümmendorf, Jolanta Dengler, Volker Kunzmann, Andreas Burchert, Petra Belohlavkova, Mohamed El Missiry, Edgar Faber, Jiří Mayer, Daniela Zackova, Panayiotis Panayiotidis, Johan Richter, Henrik Hjorth-Hansen, Magdalena Kamińska, Magdalena Płonka, Elżbieta Szczepanek, Monika Szarejko, Grażyna Bober, Iwona Hus, Olga Grzybowska-Izydorczyk, Ewa Wasilewska, Edyta Paczkowska, Joanna Niesiobędzka-Krężel, Krzysztof Giannopoulos, Francois X Mahon, Tomasz Sacha, Susanne Saussele, Markus Pfirrmann
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib. Leukemia 38 (2) (2023)
Katerina Machova Polakova, Ali Albeer, Vaclava Polivkova, Monika Krutska, Katerina Vlcanova, Nikola Curik, Alice Fabarius, Hana Klamova, Birgit Spiess, Cornelius F Waller, Tim Henrik Brümmendorf, Jolanta Dengler, Volker Kunzmann, Andreas Burchert, Petra Belohlavkova, Mohamed El Missiry, Edgar Faber, Jiří Mayer, Daniela Zackova, Panayiotis Panayiotidis, Johan Richter, Henrik Hjorth-Hansen, Magdalena Kamińska, Magdalena Płonka, Elżbieta Szczepanek, Monika Szarejko, Grażyna Bober, Iwona Hus, Olga Grzybowska-Izydorczyk, Ewa Wasilewska, Edyta Paczkowska, Joanna Niesiobędzka-Krężel, Krzysztof Giannopoulos, Francois X Mahon, Tomasz Sacha, Susanne Saussele, Markus Pfirrmann
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib. Leukemia 38 (2) (2023)
Jakub Dybaś, Aleksandra Wajda, Fatih Celal Alcicek, Magdalena Kaczmarska, Katarzyna Bulat, Ewa Szczesny-Malysiak, Agnieszka Martyna, David Perez-Guaita, Tomasz Sacha, Katarzyna Maria Marzec
Label-free testing strategy to evaluate packed red blood cell quality before transfusion to leukemia patients. Scientific reports 12 (1) (2022)
Jakub Dybaś, Aleksandra Wajda, Fatih Celal Alcicek, Magdalena Kaczmarska, Katarzyna Bulat, Ewa Szczesny-Malysiak, Agnieszka Martyna, David Perez-Guaita, Tomasz Sacha, Katarzyna Maria Marzec
Label-free testing strategy to evaluate packed red blood cell quality before transfusion to leukemia patients. Scientific reports 12 (1) (2022)
Jakub Dybaś, Aleksandra Wajda, Fatih Celal Alcicek, Magdalena Kaczmarska, Katarzyna Bulat, Ewa Szczesny-Malysiak, Agnieszka Martyna, David Perez-Guaita, Tomasz Sacha, Katarzyna Maria Marzec
Label-free testing strategy to evaluate packed red blood cell quality before transfusion to leukemia patients. Scientific reports 12 (1) (2022)
Elżbieta Szczepanek, Ositadima Chukwu, Magdalena Kamińska, Hubert Wysogląd, Agnieszka Cenda, Magdalena Zawada, Małgorzata Jakóbczyk, Joanna Wącław, Tomasz Sacha
Long-term outcomes of patients with Chronic Myeloid Leukemia who commenced treatment with imatinib: a 20-year single-centre experience. Leukemia & lymphoma 63 (9) (2022)
Jakub Dybaś, Aleksandra Wajda, Fatih Celal Alcicek, Magdalena Kaczmarska, Katarzyna Bulat, Ewa Szczesny-Malysiak, Agnieszka Martyna, David Perez-Guaita, Tomasz Sacha, Katarzyna Maria Marzec
Label-free testing strategy to evaluate packed red blood cell quality before transfusion to leukemia patients. Scientific reports 12 (1) (2022)
Jakub Dybaś, Aleksandra Wajda, Fatih Celal Alcicek, Magdalena Kaczmarska, Katarzyna Bulat, Ewa Szczesny-Malysiak, Agnieszka Martyna, David Perez-Guaita, Tomasz Sacha, Katarzyna Maria Marzec
Label-free testing strategy to evaluate packed red blood cell quality before transfusion to leukemia patients. Scientific reports 12 (1) (2022)
Timothy P Hughes, Nelma Cristina D Clementino, Mikhail Fominykh, Jeffrey H Lipton, Anna G Turkina, Elena Beatriz Moiraghi, Franck E Nicolini, Naoto Takahashi, Tomasz Sacha, Dong-Wook Kim, Rafik Fellague-Chebra, Ranjan Tiwari, Catherine Bouard, Francois-Xavier Mahon
Long-term treatment-free remission in patients with chronic myeloid leukemia after second-line nilotinib: ENESTop 5-year update. Leukemia 35 (6) (2021)
Jorge E Cortes, Jane F Apperley, Elza Lomaia, Beatriz Moiraghi, Maria Undurraga Sutton, Carolina Pavlovsky, Charles Chuah, Tomasz Sacha, Jeffrey H Lipton, Charles A Schiffer, James McCloskey, Andreas Hochhaus, Philippe Rousselot, Gianantonio Rosti, Hugues de Lavallade, Anna Turkina, Christine Rojas, Christopher Kevin Arthur, Lori Maness, Moshe Talpaz, Michael J Mauro, Tracey Hall, Vickie Lu, Shouryadeep Srivastava, Michael Deininger
Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial. Blood 138 (21) (2021)
Haifa Kathrin Al-Ali, Martin Griesshammer, Lynda Foltz, Giuseppe A Palumbo, Bruno Martino, Francesca Palandri, Anna Marina Liberati, Philipp le Coutre, Carmen García-Hernández, Andrey Zaritskey, Renato Tavares, Vikas Gupta, Pia Raanani, Pilar Giraldo, Mathias Hänel, Daniela Damiani, Tomasz Sacha, Catherine Bouard, Carole Paley, Ranjan Tiwari, Francesco Mannelli, Alessandro M Vannucchi
Primary analysis of JUMP, a phase 3b, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts. British journal of haematology 189 (5) (2020)
Markus Pfirrmann, Richard E Clark, Witold Prejzner, Michael Lauseker, Michele Baccarani, Susanne Saussele, François Guilhot, Sonja Heibl, Rüdiger Hehlmann, Edgar Faber, Anna G Turkina, Gert Ossenkoppele, Martin Höglund, Andrey Zaritskey, Laimonas Griskevicius, Ulla Olsson-Strömberg, Hele Everaus, Perttu Koskenvesa, Boris Labar, Tomasz Sacha, Daniela Zackova, Francisco Cervantes, Adriana Colita, Irena Zupan, Andrija Bogdanovic, Fausto Castagnetti, Joëlle Guilhot, Joerg Hasford, Andreas Hochhaus, Verena S Hoffmann
The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia. Leukemia 34 (8) (2020)
Michael Lauseker, Katharina Bachl, Anna Turkina, Edgar Faber, Witold Prejzner, Ulla Olsson-Strömberg, Michele Baccarani, Elza Lomaia, Daniela Zackova, Gert Ossenkoppele, Laimonas Griskevicius, Gabriele Schubert-Fritschle, Tomasz Sacha, Sonja Heibl, Perttu Koskenvesa, Andrija Bogdanovic, Richard E Clark, Joelle Guilhot, Verena S Hoffmann, Joerg Hasford, Andreas Hochhaus, Markus Pfirrmann
Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin. American journal of hematology 94 (11) (2019)
Zdenek Rácil, Eva Koritakova, Tomasz Sacha, Hana Klamova, Petra Belohlavkova, Edgar Faber, Delphine Rea, Ludmila Malaskova, Jirina Prochazkova, Daniela Zackova, Jaroslava Voglova, Joanna Wącław, Petr Cetkovsky, Pavel Zak, Jiri Mayer
Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy. American journal of hematology 93 (10) (2018)
Tomasz Sacha, Joanna Góra-Tybor, Monika Szarejko, Grażyna Bober, Olga Grzybowska-Izydorczyk, Joanna Niesiobędzka-Krężel, Marek Dudziński, Ewa Wasilewska, Krzysztof Myśliwiec, Justyna Gil, Michał Gniot, Iwona Pietkun, Ewa Mędraś, Jadwiga Hołojda, Joanna Wącław, Krzysztof Giannopoulos
A multicenter prospective study on efficacy and safety of imatinib generics: A report from Polish Adult Leukemia Group imatinib generics registry. American journal of hematology 92 (7) (2017)

Tomasz Sacha.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tomasz Sacha